The "Chinese Expert Consensus on the Ethical Review of Clinical Research of Ophthalmic Gene Therapy (2022)" provides guidelines for ethically conducting gene therapy research in ophthalmology. Developed by experts from the Chinese Vitreo-Retina Society and the Fundus Disease Committee, it emphasizes balancing patient protection with innovation. Key points include the need for rigorous ethical reviews, qualified medical institutions for trials, diverse expert involvement, informed consent, patient safety, and long-term monitoring of participants. The consensus aims to ensure responsible gene therapy research while promoting scientific progress.